Ractopamine HCl

Ractopamine HCl (CAS No.: 90274-24-1) is a synthetic phenethanolamine class small molecule that is primarily categorized as a beta adrenergic receptor agonist and is widely used as a pharmacological research tool in comparative physiology, receptor pharmacology, and agricultural bioscience related to metabolic regulation in animal systems. Mechanistically, it activates beta adrenergic signaling with documented high affinity interactions at porcine beta1 and beta2 adrenergic receptors in the nanomolar range and additional agonist activity at trace amine associated receptor 1 at micromolar levels, supporting investigation of cyclic AMP linked signaling networks, downstream protein synthesis control, and coordinated regulation of lipid and muscle metabolic programs. In experimental settings, its in vitro activity profile is generally described as spanning nanomolar to low micromolar concentrations depending on receptor subtype, cell background, and assay format, and it is therefore applicable to receptor binding studies, second messenger assays, target deconvolution workflows, and pathway focused screening platforms in biomedical discovery research. In vivo and ex vivo research applications commonly involve animal and tissue models to examine shifts in nutrient partitioning, protein accretion, and adipose deposition under adrenergic stimulation, while study specific concentrations or doses are typically selected according to experimental design, species context, and endpoint sensitivity. Overall, this compound is most appropriately positioned in research catalogs as a receptor selective metabolic signaling modulator for mechanistic studies and translationally relevant preclinical model development in life sciences and drug discovery pipelines, with use restricted to controlled laboratory research contexts only.